CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMAS
- 1 June 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (6) , 1984-1987
- https://doi.org/10.1016/s0022-5347(05)68869-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinomaCancer, 1997
- Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinomaHuman Pathology, 1997
- Classification of renal cell carcinomaCancer, 1997
- Significance of conventional and new prognostic factors for locally confined renal cell carcinomaCancer, 1995
- CD44 variant exon epitopes in primary breast cancer and length of survivalThe Lancet, 1995
- A comparative analysis of grading systems in renal adenocarcinomaHistopathology, 1994
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- Renal cell carcinoma.Prognostic significance of morphologic parameters in 121 casesCancer, 1988
- Prognostic significance of morphologic parameters in renal cell carcinomaThe American Journal of Surgical Pathology, 1982